ObsEva (OBSV) Competitors Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsSEC FilingsTrends OBSV vs. CEMI, ACST, CTXR, PMN, LIAN, BIVI, SRZN, HCWB, RNXT, and BLRXShould you be buying ObsEva stock or one of its competitors? The main competitors of ObsEva include Chembio Diagnostics (CEMI), Acasti Pharma (ACST), Citius Pharmaceuticals (CTXR), ProMIS Neurosciences (PMN), LianBio (LIAN), BioVie (BIVI), Surrozen (SRZN), HCW Biologics (HCWB), RenovoRx (RNXT), and BioLineRx (BLRX). These companies are all part of the "medical" sector. ObsEva vs. Chembio Diagnostics Acasti Pharma Citius Pharmaceuticals ProMIS Neurosciences LianBio BioVie Surrozen HCW Biologics RenovoRx BioLineRx ObsEva (NASDAQ:OBSV) and Chembio Diagnostics (NASDAQ:CEMI) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, earnings, media sentiment, valuation, profitability, community ranking, dividends, risk and analyst recommendations. Is OBSV or CEMI more profitable? ObsEva has a net margin of 0.00% compared to Chembio Diagnostics' net margin of -47.03%. Chembio Diagnostics' return on equity of -113.57% beat ObsEva's return on equity.Company Net Margins Return on Equity Return on Assets ObsEvaN/A -416.36% -92.01% Chembio Diagnostics -47.03%-113.57%-38.22% Do institutionals & insiders believe in OBSV or CEMI? 17.5% of ObsEva shares are held by institutional investors. Comparatively, 8.6% of Chembio Diagnostics shares are held by institutional investors. 14.4% of ObsEva shares are held by company insiders. Comparatively, 3.3% of Chembio Diagnostics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Which has better valuation & earnings, OBSV or CEMI? Chembio Diagnostics has higher revenue and earnings than ObsEva. Chembio Diagnostics is trading at a lower price-to-earnings ratio than ObsEva, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioObsEva$20.11M0.00-$58.38M-$0.92N/AChembio Diagnostics$48.34M0.35-$23.29M-$1.20-0.38 Does the MarketBeat Community prefer OBSV or CEMI? ObsEva received 46 more outperform votes than Chembio Diagnostics when rated by MarketBeat users. Likewise, 51.45% of users gave ObsEva an outperform vote while only 51.03% of users gave Chembio Diagnostics an outperform vote. CompanyUnderperformOutperformObsEvaOutperform Votes31951.45% Underperform Votes30148.55% Chembio DiagnosticsOutperform Votes27351.03% Underperform Votes26248.97% Does the media prefer OBSV or CEMI? In the previous week, ObsEva had 1 more articles in the media than Chembio Diagnostics. MarketBeat recorded 1 mentions for ObsEva and 0 mentions for Chembio Diagnostics. ObsEva's average media sentiment score of 0.00 equaled Chembio Diagnostics'average media sentiment score. Company Overall Sentiment ObsEva Neutral Chembio Diagnostics Neutral Which has more volatility & risk, OBSV or CEMI? ObsEva has a beta of 0.68, indicating that its stock price is 32% less volatile than the S&P 500. Comparatively, Chembio Diagnostics has a beta of 1.85, indicating that its stock price is 85% more volatile than the S&P 500. SummaryObsEva beats Chembio Diagnostics on 8 of the 13 factors compared between the two stocks. Ad Brownstone ResearchMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrough so advanced, it’s going to make ChatGPT look like VHS. But what’s even more unbelievable? I believe it’ll make Nvidia’s meteoric rise look like a backyard bottle rocket.Click here and I’ll tell you everything you need to know. Get ObsEva News Delivered to You Automatically Sign up to receive the latest news and ratings for OBSV and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OBSV vs. The Competition Export to ExcelMetricObsEvaPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$7.94M$6.48B$5.07B$8.80BDividend YieldN/A8.11%4.99%4.07%P/E Ratio-0.114.9789.5613.60Price / SalesN/A371.451,224.8087.40Price / CashN/A52.5939.4536.27Price / BookN/A10.306.976.33Net Income-$58.38M$153.61M$119.04M$225.93M ObsEva Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OBSVObsEvaN/AN/AN/AN/A$7.94M$20.11M-0.1150CEMIChembio DiagnosticsN/A$0.46flatN/A+0.0%$16.71M$48.34M-0.38337Analyst ForecastACSTAcasti Pharma2.3584 of 5 stars$3.37-0.9%$10.00+196.7%+59.0%$31.68MN/A-2.3432CTXRCitius Pharmaceuticals3.152 of 5 stars$0.18+3.1%$4.00+2,184.4%-77.9%$31.65MN/A-0.7120Short Interest ↓PMNProMIS Neurosciences1.1141 of 5 stars$0.96-3.7%N/A-30.8%$31.38M$10,000.000.006Gap DownLIANLianBio1.1178 of 5 stars$0.29flat$3.50+1,115.5%-93.1%$31.12MN/A-0.35110BIVIBioVie0.6196 of 5 stars$3.28-2.4%$4.00+22.0%-24.0%$30.60MN/A0.0010SRZNSurrozen1.4586 of 5 stars$9.32+4.7%N/A+25.6%$30.29M$12.50M0.0042Gap DownHCWBHCW Biologics1.1093 of 5 stars$0.80-15.6%N/A-12.3%$30.22M$2.84M0.0040Gap DownRNXTRenovoRx2.6223 of 5 stars$1.24+4.6%$6.13+392.2%+98.7%$29.87MN/A-2.126News CoveragePositive NewsGap UpBLRXBioLineRx1.9751 of 5 stars$0.37-32.2%$21.00+5,584.9%-67.9%$29.53M$4.80M0.0040News CoverageHigh Trading Volume Related Companies and Tools Related Companies Chembio Diagnostics Alternatives Acasti Pharma Alternatives Citius Pharmaceuticals Alternatives ProMIS Neurosciences Alternatives LianBio Alternatives BioVie Alternatives Surrozen Alternatives HCW Biologics Alternatives RenovoRx Alternatives BioLineRx Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:OBSV) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ObsEva SA Please log in to your account or sign up in order to add this asset to your watchlist. Share ObsEva With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
